Home/Filings/4/0001127602-23-027415
4//SEC Filing

FOSTER JAMES C 4

Accession 0001127602-23-027415

CIK 0001100682other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 9:23 AM ET

Size

9.7 KB

Accession

0001127602-23-027415

Insider Transaction Report

Form 4
Period: 2023-11-14
FOSTER JAMES C
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-11-14$178.05/sh+5,620$1,000,641202,643 total
Holdings
  • Common Stock

    (indirect: 2021 GRAT)
    4,328
  • Common Stock

    (indirect: 2022 GRAT)
    11,000
  • Common Stock

    (indirect: 2023 GRAT)
    20,000
  • Common Stock

    (indirect: By Trust)
    340
  • Common Stock

    (indirect: By Trust)
    750
  • Common Stock

    (indirect: By Trust)
    2,250
  • Common Stock

    (indirect: By Spouse)
    10,000
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $177.99 to $178.11. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1
  • filerCIK 0001141722

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 9:23 AM ET
Size
9.7 KB